# Canaan's Biotech Investments: 52 Startups in Its Portfolio (2026) > The 52 Biotech startups Canaan has backed, by stage: $4.7B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/canaan-partners-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 14 - [Unchained Labs](https://millionrounds.com/company/unchained-labs) - [ReVision Optics](https://millionrounds.com/company/revision-optics) - [*D* Dermira](https://millionrounds.com/company/dermira) - [Civitas Therapeutics](https://millionrounds.com/company/civitas-therapeutics) - [AgomAB Therapeutics](https://millionrounds.com/company/agomab-therapeutics) - [Synthekine](https://millionrounds.com/company/synthekine) - [Genome Medical](https://millionrounds.com/company/genome-medical) - [Protagonist Therapeutics](https://millionrounds.com/company/protagonist-therapeutics) - [Antiva Biosciences](https://millionrounds.com/company/antiva-biosciences) - [Vivace Therapeutics](https://millionrounds.com/company/vivace-therapeutics) - [*CM* Calibra Medical](https://millionrounds.com/company/calibra-medical) - [OncoResponse](https://millionrounds.com/company/oncoresponse) - [Sample6](https://millionrounds.com/company/sample6) - [*A* Antiva](https://millionrounds.com/company/antiva) ## Series B 13 - [Greywolf Therapeutics](https://millionrounds.com/company/grey-wolf-therapeutics) - [*HT* Halda Therapeutics](https://millionrounds.com/company/halda-therapeutics) - [Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics) - [Nocion Therapeutics](https://millionrounds.com/company/nocion-therapeutics) - [*T* Tia](https://millionrounds.com/company/tia) - [*I* Ideaya](https://millionrounds.com/company/ideaya) - [*CT* Chrono Therapeutics](https://millionrounds.com/company/chrono-therapeutics) - [Normunity](https://millionrounds.com/company/normunity) - [Actio Biosciences](https://millionrounds.com/company/actio-biosciences) - [Acesion Pharma](https://millionrounds.com/company/acesion-pharma) - [Vineti](https://millionrounds.com/company/vineti) - [Pathios Therapeutics](https://millionrounds.com/company/pathios-therapeutics) - [NextCure](https://millionrounds.com/company/nextcure) ## Series A 13 - [*VT* Vima Therapeutics](https://millionrounds.com/company/vima-therapeutics) - [Envisia Therapeutics](https://millionrounds.com/company/envisia-therapeutics) - [Vedana Therapeutics](https://millionrounds.com/company/vedana-therapeutics) - [*LB* Labrys Biologics](https://millionrounds.com/company/labrys-biologics) - [Rallybio](https://millionrounds.com/company/rallybio) - [Alphina Therapeutics](https://millionrounds.com/company/alphina-therapeutics) - [*CT* Comet Therapeutics](https://millionrounds.com/company/comet-therapeutics) - [Dauntless](https://millionrounds.com/company/dauntless) - [Spyryx Biosciences](https://millionrounds.com/company/spyryx-biosciences) - [Data Sciences International](https://millionrounds.com/company/data-sciences-international) - [LQ3 Pharmaceuticals](https://millionrounds.com/company/lq3-pharmaceuticals) - [Uniform Teeth](https://millionrounds.com/company/uniform-teeth) - [*IB* Intrepida Bio](https://millionrounds.com/company/intrepida-bio) ## Stage not reported 12 - [IDEAYA Biosciences](https://millionrounds.com/company/ideaya-biosciences) - [Tyra Biosciences](https://millionrounds.com/company/tyra-biosciences) - [EndoGastric Solutions](https://millionrounds.com/company/endogastric-solutions) - [Arvinas](https://millionrounds.com/company/arvinas) - [Semnur Pharmaceuticals](https://millionrounds.com/company/semnur-pharmaceuticals) - [*E* EndoGastric](https://millionrounds.com/company/endogastric) - [*CS* Cyrano Sciences](https://millionrounds.com/company/cyrano-sciences) - [Transposon Therapeutics](https://millionrounds.com/company/transposon-therapeutics) - [Abyrx](https://millionrounds.com/company/abyrx) - [*A* Abryx](https://millionrounds.com/company/abryx) - [Ambra Health](https://millionrounds.com/company/ambra-health) - [ThirtyFiveBio](https://millionrounds.com/company/thirtyfivebio) ## Segment by segment ### Series C and later 14 startups · $1.3B raised - [**Unchained Labs**](https://millionrounds.com/company/unchained-labs) Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it. United States $193M - [**ReVision Optics**](https://millionrounds.com/company/revision-optics) ReVision Optics offers PRESBYLENS, a refractive surgery solution to correct vision loss by the natural aging process. United States $172M - [*D* **Dermira**](https://millionrounds.com/company/dermira) Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology. United States $169M - [**Civitas Therapeutics**](https://millionrounds.com/company/civitas-therapeutics) Civitas develops pulmonary delivery therapies. United States $122M - [**AgomAB Therapeutics**](https://millionrounds.com/company/agomab-therapeutics) AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues. Belgium $112M - [**Synthekine**](https://millionrounds.com/company/synthekine) Synthekine is a biotechnology company based in Menlo Park, California, founded in 2018. United States $100M - [**Genome Medical**](https://millionrounds.com/company/genome-medical) Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine. United States $98M - [**Protagonist Therapeutics**](https://millionrounds.com/company/protagonist-therapeutics) Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discoveri Australia $89M ### Series B 13 startups · $1.1B raised - [**Greywolf Therapeutics**](https://millionrounds.com/company/grey-wolf-therapeutics) Greywolf Therapeutics is a clinical-stage biotechnology company based in Oxford, United Kingdom. United Kingdom $144M - [*HT* **Halda Therapeutics**](https://millionrounds.com/company/halda-therapeutics) Halda Therapeutics is a research-stage drug discovery company. United States $126M - [**Arrakis Therapeutics**](https://millionrounds.com/company/arrakis-therapeutics) Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases. United States $113M - [**Nocion Therapeutics**](https://millionrounds.com/company/nocion-therapeutics) Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. United States $112M - [*T* **Tia**](https://millionrounds.com/company/tia) United States $103M - [*I* **Ideaya**](https://millionrounds.com/company/ideaya) United States $94M - [*CT* **Chrono Therapeutics**](https://millionrounds.com/company/chrono-therapeutics) Chrono Therapeutics was founded by Guy DiPierro to cause a paradigm shift in the way addictions and diseases are treated. United States $83M - [**Normunity**](https://millionrounds.com/company/normunity) Normunity is a biotechnology company founded in 2020, focused on developing innovative precision immuno-oncology therapies. United States $75M ### Series A 13 startups · $434M raised - [*VT* **Vima Therapeutics**](https://millionrounds.com/company/vima-therapeutics) United States $100M - [**Envisia Therapeutics**](https://millionrounds.com/company/envisia-therapeutics) Envisia Therapeutics is a biotechnology company based in Research Triangle Park, North Carolina, established in 2013 by Liquidia T United States $46M - [**Vedana Therapeutics**](https://millionrounds.com/company/vedana-therapeutics) Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention. United States $46M - [*LB* **Labrys Biologics**](https://millionrounds.com/company/labrys-biologics) Labrys Biologics develops treatments for chronic migraine. - $46M - [**Rallybio**](https://millionrounds.com/company/rallybio) Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease. United States $44M - [**Alphina Therapeutics**](https://millionrounds.com/company/alphina-therapeutics) Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. United States $40M - [*CT* **Comet Therapeutics**](https://millionrounds.com/company/comet-therapeutics) Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders. United States $29M - [**Dauntless**](https://millionrounds.com/company/dauntless) Dauntless is a Seattle-area software developer providing point-of-sale and tracking software to the cannabis industry. United States $25M ### Stage not reported 12 startups · $1.8B raised - [**IDEAYA Biosciences**](https://millionrounds.com/company/ideaya-biosciences) IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers. United States $608M - [**Tyra Biosciences**](https://millionrounds.com/company/tyra-biosciences) Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. United States $600M - [**EndoGastric Solutions**](https://millionrounds.com/company/endogastric-solutions) EndoGastric Solutions is a medical device company based in Redmond, Washington. United States $293M - [**Arvinas**](https://millionrounds.com/company/arvinas) Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics. United States $111M - [**Semnur Pharmaceuticals**](https://millionrounds.com/company/semnur-pharmaceuticals) Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products. United States $106M - [*E* **EndoGastric**](https://millionrounds.com/company/endogastric) United States $31M - [*CS* **Cyrano Sciences**](https://millionrounds.com/company/cyrano-sciences) Cyrano Sciences, is focused on providing chemical and biological sensors and software solutions. United States $23M - [**Transposon Therapeutics**](https://millionrounds.com/company/transposon-therapeutics) Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases. United States $22M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Canaan as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Canaan's Fintech portfolio** 18 startups · $851M](https://millionrounds.com/portfolio-maps/canaan-partners-fintech-portfolio)[Sector portfolio **Canaan's AI portfolio** 17 startups · $2.2B](https://millionrounds.com/portfolio-maps/canaan-partners-ai-portfolio)[Sector portfolio **Canaan's Internet portfolio** 14 startups · $535M](https://millionrounds.com/portfolio-maps/canaan-partners-internet-portfolio)[Sector portfolio **Canaan's IT Services portfolio** 13 startups · $434M](https://millionrounds.com/portfolio-maps/canaan-partners-it-services-portfolio)[Co-investors **Who invests with Canaan** 234 co-investors](https://millionrounds.com/portfolio-maps/canaan-partners-co-investors)[Portfolio map **Canaan portfolio map** 164 startups · $14B](https://millionrounds.com/portfolio-maps/canaan-partners-portfolio-map) ## Raising from investors like Canaan? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)